Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gandhi, IN
Abbasi A. Gandhi, Ahmedabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20110114230 | Nickel-Titanium-Rare Earth Alloy and Method of Processing the Alloy - A nickel-titanium-rare earth (Ni—Ti-RE) alloy comprises nickel at a concentration of from about 35 at. % to about 65 at. %, a rare earth element at a concentration of from about 1.5 at. % to about 15 at. %, boron at a concentration of up to about 0.1 at. %, with the balance of the alloy being titanium. In addition to enhanced radiopacity compared to binary Ni—Ti alloys and improved workability, the Ni—Ti-RE alloy preferably exhibits superelastic behavior. A method of processing a Ni—Ti-RE alloy includes providing a nickel-titanium-rare earth alloy comprising nickel at a concentration of from about 35 at. % to about 65 at. %, a rare earth element at a concentration of from about 1.5 at. % to about 15 at. %, the balance being titanium; heating the alloy in a homogenization temperature range below a critical temperature; and forming spheroids of a rare earth-rich second phase in the alloy while in the homogenization temperature range. | 05-19-2011 |
Anikumar S. Gandhi, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20080248107 | Controlled Release Formulation - The present invention provides a controlled release formulation comprising an therapeutically effective amount of pharmacologically active substance having high water solubility, at least one non-polymeric release retardant, and at least one pH independent non-swelling release retarding polymer. The said dosage form provides controlled release of the active agent with reduced initial burst release. | 10-09-2008 |
Anikumar Surendrakumar Gandhi, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20110189109 | COMPOSITIONS COMPRISING FENUGREEK HYDROCOLLOIDS - The present invention discloses compositions comprising fenugreek hydrocolloids comprising soluble and insoluble dietary fibers. The present invention further relates to the use of these compositions comprising fenugreek hydrocolloids as healthcare, personal care, food, household care and industrial products. | 08-04-2011 |
Anilkumar Gandhi, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20090087485 | Orally Disintegrating Tablets - The present invention describes a directly compressible composite excipient prepared by coating calcium silicate with a carbohydrate. The present invention further describes the incorporation of the composite excipient into a tablet formulation. The orally disintegrating tablets are of optimal mechanical strength and disintegrate within 60 seconds in the oral cavity. | 04-02-2009 |
Anilkumar S. Gandhi, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20090053310 | NOVEL SUSTAINED RELEASE DOSAGE FORM - The novel sustained release dosage form comprising an active agent and a combination of a non-swelling pH dependent release retardant and a non swelling pH independent release retardant polymer which provides pH-independent drug release for a considerable period of time after administration. | 02-26-2009 |
| 20090123543 | PHARMACEUTICAL COMPOSITIONS - A novel solid oral dosage form comprising a therapeutically effective amount of hydrophobic pharmacological active ingredient and at least one particle separating agent preferably selected from a class of wetting agents, prepared without or with minimum amount of a disintegrating agent. The hydrophobic pharmacological active ingredient active ingredient belongs to the class of angiotensin receptor blocking agents preferably is valsartan optionally in combination with hydrochlorothiazide. The active ingredient may also be a class of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors preferably atorvastatin. The ratio of hydrophobic active ingredient to particle separating agent is about 20:1 to about 1:20. The process for the preparation of the novel solid oral dosage form comprises treating a hydrophobic active ingredient with at least one particle separating agent, and incorporating the treated hydrophobic active ingredient into a solid dosage form. | 05-14-2009 |
| 20090208576 | Orally Disintegrating Tablets - The present invention describes a directly compressible composite prepared by co-processing a water-soluble excipient and calcium silicate. The present invention further describes the incorporation of the co-processed composite into a tablet formulation. The orally disintegrating tablets are of optimal mechanical strength and disintegrate within 60 seconds in the oral cavity. | 08-20-2009 |
| 20100119607 | BIOENHANCED COMPOSITIONS - The present invention relates to the method of increasing the bioavailability of Angiotensin II Receptor Blockers (ARBs) by preparing a composition of an ARB with at least one solubility enhancing agent. The invention is particularly focused to provide a novel or modified dissolution profile where the release of ARB in the GI tract is independent of physiological pH conditions. | 05-13-2010 |
Anilkumar Surendrakumar Gandhi, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20080312168 | Novel Dispersible Tablet Composition - The present invention relates to a novel dispersible tablet composition, which comprises of a pharmacologically active ingredient and at least one excipient, which reduces the sedimentation rate of active ingredient. This invention further relates to a process for the preparation of a dispersible tablet of a pharmacologically active ingredient. | 12-18-2008 |
| 20100215740 | TASTE-MASKED ORALLY DISINTEGRATING TABLETS OF MEMANTINE HYDROCHLORIDE - The present invention relates to a solid pharmaceutical composition comprising memantine, which dissolves or disintegrates in the oral cavity preferably within about 60 seconds. The present invention further discloses orally disintegrating tablets of taste-masked memantine of optimal mechanical strength comprising memantine along with a taste-masking agent and pharmaceutically acceptable excipients. | 08-26-2010 |
| 20110177175 | DIETARY FIBER COMPOSITIONS - The present invention relates to dietary fiber compositions comprising fenugreek dietary fibers. The present invention also relates to use of these compositions as dietary supplements, functional foods or pharmaceutical preparations for promoting satiety and weight loss, lowering cholesterol, controlling blood glucose, maintaining colon health and modulating inflammation. | 07-21-2011 |
| 20120093738 | TASTE-MASKED ORAL FORMULATIONS OF INFLUENZA ANTIVIRALS - The present invention relates to taste-masked oral formulations of influenza antivirals. The taste-masked pharmaceutical formulations for oral administration comprise one or more influenza antivirals, at least one taste-masking agent and at least one pharmaceutically acceptable excipient. Further, the taste-masked influenza antiviral formulations of the present invention are provided in the form of dispersible tablets, effervescent tablets, orally disintegrating tablets, chewable tablets, bite-dispersion tablets or the like, wherein the bitter taste of influenza antivirals is masked thereby providing palatable formulations. | 04-19-2012 |
Anilkumar Surendrakumar Gandhi, Maharashtra IN
| Patent application number | Description | Published |
|---|---|---|
| 20110229569 | COMPOSITIONS EXHIBITING DELAYED TRANSIT THROUGH THE GASTROINTESTINAL TRACT - The present invention provides a composition exhibiting delayed transit through the gastrointestinal tract comprising one or more active agents, fenugreek fiber and at least one pharmaceutically acceptable excipient. The present invention further relates to gastroretentive dosage forms comprising fenugreek fibers. | 09-22-2011 |
Hiren Gandhi, Navsari IN
| Patent application number | Description | Published |
|---|---|---|
| 20090076271 | Process for preparing intermediates of HMG-CoA reductase inhibitors - The present invention relates to intermediates of rosuvastatin and processes for the production thereof. | 03-19-2009 |
| 20090209779 | Process for preparing intermediates of HMG-CoA reductase inhibitors - The present invention relates to intermediates of rosuvastatin and processes for the production thereof. | 08-20-2009 |
| 20100160663 | PROCESS FOR PREPARING INTERMEDIATES OF HMG-CoA REDUCTASE INHIBITORS - The present invention relates to intermediates of rosuvastatin and processes for the production thereof. | 06-24-2010 |
Kamlesh Gandhi, Andra Pradesh IN
| Patent application number | Description | Published |
|---|---|---|
| 20120042146 | DEVICE AND METHOD FOR STORAGE, RETRIEVAL, RELOCATION, INSERTION OR REMOVAL OF DATA IN STORAGE UNITS - A method and system for managing data in a storage unit is provided. The method includes insertion, removal and relocation of data by maintaining and using spare capacity in the storage unit. The method includes relocation of one or more data elements by remapping data in a storage unit. The method further includes insertion of one or more data elements in a storage block of a storage unit. The method also further includes removal of one or more data elements from a storage block of a storage unit. Furthermore, the method includes insertion of one or more ranges of addresses in storage blocks. The method also includes removal of one or more storage blocks from the storage unit. | 02-16-2012 |
Maheshkumar Ramniklal Gandhi, Bhavnagar IN
| Patent application number | Description | Published |
|---|---|---|
| 20100172812 | PROCESS FOR THE PREPARATION OF MAGNESIA (MGO) - The present invention provides an improved process for the preparation of MgO of high purity >99% from salt bitterns via intermediate formation of Mg(OH) | 07-08-2010 |
Mahesh Ramaniklal Gandhi, Bhavnagar IN
| Patent application number | Description | Published |
|---|---|---|
| 20090188810 | Process for the Preparation of Stable Iodate-Exchanged Synthetic Hydrotalcite with Zero Effluent Discharge - The present invention relates to a process for the preparation of stable iodate-exchanged hydrotalcite with zero effluent discharge. The iodate-exchanged hydrotalcite produced is useful as iodizing agent. The invention further relates to utilization of alkaline effluent generated in the process of ion exchange of iodate into SHT so as to fully recycle the residual iodate anion and also utilize the alkali generated in the process for production of additional quantities of iodate through reaction with iodine crystals followed by electrochemical oxidation to obtain pure aqueous solution of iodate salt which can be reused for preparation of the stable iodizing agent. The process gives zero effluent discharge hence economical. | 07-30-2009 |
Mahesh Ramnikla Gandhi, Bhavnagar IN
| Patent application number | Description | Published |
|---|---|---|
| 20110008497 | Iodized Salt and a Process for Its Preparation - The invention discloses a novel iodizing agent containing latent elemental iodine and preparation of iodized salt therefrom. The iodizing agent comprises a mixture of iodide and iodate in solution form in 5:1 molar ratio. The said iodizing agent may be prepared cost-effectively through the reaction of pure iodine crystals with a suitable alkali. Iodized salt prepared therefrom is stable in the pH range of 7.0-8.0 whereas it releases the latent elemental iodine under acidic conditions such as that which prevails in the stomach. | 01-13-2011 |
Mitesh Gandhi, Gujarat IN
| Patent application number | Description | Published |
|---|---|---|
| 20090054634 | Process for the preparation of clarithromycin - The present invention includes a process involving a one-pot reaction for preparing erythromycin 9-oxime salt comprising: (a) reacting erythromycin thiocyanate with an ammonium source to obtain erythromycin free base; (b) oximating the C-9 carbonyl of the erythromycin free base by reacting the erythromycin free base with triethylamine and hydroxyl amine hydrochloride to form erythromycin oxime; and (c) reacting the erythromycin oxime obtained in step (b) with an ammonium source to obtain the erythromycin 9-oxime salt. The present invention is also drawn to a one-pot reaction for preparing clarithromycin starting with the one-pot reaction for preparing erythromycin 9-oxime salt, further comprising after step (c): (d) silylating the hydroxy groups at the oxime group, and the 2′ and 4″ positions of the erythromycin 9-oxime salt to obtain a silylated derivative; (e) methylating the hydroxy group at the 6 position of the silylated derivative using at least one methylating agent in the presence of at least one inorganic base to obtain SMOP, wherein SMOP is 6-O-methyl-2′,4″-bis(trimethylsilyl)-erythromycin A 9-O-(2-methoxyprop-2-yl)oxime; and (f) converting the SMOP into clarithromycin using at least one deoximating agent in the presence of aqueous ethanol. | 02-26-2009 |
Neha Rajendraprasad Gandhi, Nagpur IN
| Patent application number | Description | Published |
|---|---|---|
| 20120124312 | HOST DISCOVERY AND HANDLING OF ALUA PREFERENCES AND STATE TRANSITIONS - Various systems and methods can discover asymmetric logical unit (LUN) access (ALUA) preferences and/or state transitions and use those preferences and/or state transitions to control how a host accesses a LUN in an ALUA array. One such method involves detecting a preferred controller for a LUN and then detecting that a current owner controller of the LUN is not the preferred controller. In response, the method can initiate an ownership change from the current owner controller to the preferred controller. Another method involves detecting an initial state of a first controller with respect to a LUN. The method then detects a subsequent state of the first controller with respect to the LUN subsequent to detecting the initial state. The method can then cause a computing device to access the LUN via a second controller, in response to the subsequent state not being the active optimized state. | 05-17-2012 |
Pankaj Gandhi, Surat (gujarat) IN
| Patent application number | Description | Published |
|---|---|---|
| 20110264188 | RE-ESTABLISHMENT OF BLOOD FLOW IN BLOCKED HUMAN ARTERIES BY TRANSFERRING NANO-ENCAPSULATED DRUG THROUGH MEDICAL DEVICES, DESIGNED FOR THE SAME AND RELEASING THE NANO-ENCAPSULATED DRUG IN HUMAN ARTERY WITH BODY PH - A drug-delivering insertable medical device for treating a medical condition associated with a body lumen is disclosed. The drug-delivering insertable medical device includes an outer surface coated with two or more nano-carriers having two or more average diameters. A nano-carrier of the two or more nano-carriers has an average diameter suitable for penetrating one or more layers of two or more layers of the body lumen. The nano-carrier includes a drug surrounded by an encapsulating medium. The encapsulating medium includes one or more of a biological agent, a blood excipient, and a phospholipid. | 10-27-2011 |
| 20120065584 | REJUVENATING CORONARY ARTERY BY IMPROVING BLOOD FLOW WITH THE HELP OF INSERTION OF NANO-BALLS (ENCAPSULATED NANOPARTICLES) CONTAINING THERAPEUTIC AGENTS BY NON IMPLANTABLE DEVICE FOR TISSUES AND THEREBY PROVIDING IN TISSUE RELEASE TO ADDRESS THE REQUIRED CELL CYCLE - A drug-delivering medical device for delivering a drug to a target site in a body lumen is disclosed. The drug-delivering medical device includes a balloon catheter and an inflatable balloon positioned on the balloon catheter. The inflatable balloon has a hydrophilic surface. One or more portions of the hydrophilic surface are coated with two or more nano-carriers. A nano-carrier of the two or more nano-carriers includes a drug surrounded by an encapsulating medium. As the drug is surrounded by the encapsulating medium, the surface of the nano-carrier is devoid of the drug. When the inflatable balloon is inflated upon coming in proximity to a target site in the body lumen, about 30% to 80% of the two or more nano-carriers are released from the hydrophilic surface within 15-90 seconds. | 03-15-2012 |
Pawan Deep Gandhi, Faridabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20110296265 | SYSTEM FOR TESTING INTEGRATED CIRCUIT WITH ASYNCHRONOUS CLOCK DOMAINS - A system for scan testing various clock domains of an integrated circuit includes a clock gate control unit and clock gating cells. The clock gating cells receive a single test clock signal provided externally through one package pin of the integrated circuit. The clock gate control unit provides clock gate control signals to the clock gating cells. The clock gating cells generate time-staggered clock signals based on the clock gate control signals. | 12-01-2011 |
Pawan Mansukhlal Gandhi, Pune IN
| Patent application number | Description | Published |
|---|---|---|
| 20090193836 | ARTICULATED FREEZER DRAWERS - The invention relates generally to an articulating drawer for a bottom mount freezer refrigerator. The drawer can be slideably mounted in the freezer compartment on slides that can include pivots to pivotally mount a drawer front on the slides. A support mechanism can mount a food storage basket for movement with the drawer front and movable slides and can move the food storage basket upward when the door is moved to the open position. The support mechanism can include a pair of guide plates connected to the slides having a guide surface arranged to be engaged by a food storage basket guide surface follower and a pair of links each connected to the drawer front at one end and having a first link pivot at a distal end arranged to pivotally connect to a food storage basket pivot. | 08-06-2009 |
Peeyush Gandhi, Shaikpet IN
| Patent application number | Description | Published |
|---|---|---|
| 20110208804 | CENTRALIZED MANAGEMENT TOOL FOR REMOTE PRESENTATION SESSION SERVER FARMS - Systems, methods, and computer-readable storage media are disclosed for configuring and managing a remote presentation session server farm. In an example embodiment, a central management server (CMS) receives a task to be carried out on a server farm (e.g. make an otherwise unused server operate as a remote presentation session server). The CMS then validates this request against a model of allowed tasks, and the current configuration of the server farm. Once validated, the CMS converts the task into operations to be carried out by one or more servers of the server farm. The CMS then sends these operations to the respective servers, where the operations are received by an agent process executing on the server. Each agent performs the received operations on the server upon which it executes, and sends an indication of whether the operations were completed successfully to the CMS. The CMS may then update its model and current configuration to reflect the current configuration of the server farm. | 08-25-2011 |
Rajesh Gandhi, Sagar IN
| Patent application number | Description | Published |
|---|---|---|
| 20110077281 | Formulations Comprising Triptain Compounds - The invention provides a pharmaceutical composition for intranasal administration comprising a salt of sumatriptan or a physiologically acceptable solvate thereof, an alkyl glycoside or saccharide alkyl ester and optionally at least one pharmaceutically acceptable excipient, wherein the said composition provides T | 03-31-2011 |
Rajesh Gandhi, Gurgaon IN
| Patent application number | Description | Published |
|---|---|---|
| 20090068266 | SIROLIMUS HAVING SPECIFIC PARTICLE SIZE AND PHARMACEUTICAL COMPOSITIONS THEREOF - Sirolimus particles having d | 03-12-2009 |
| 20090130210 | PHARMACEUTICAL COMPOSITIONS OF SIROLIMUS - A pharmaceutical composition of sirolimus comprising an inert core and a sugar overcoat, wherein said sugar overcoat comprises sirolimus, a poloxamer other than poloxamer 188, microcrystalline cellulose and binder has been developed. | 05-21-2009 |
| 20100144800 | EXTENDED RELEASE TABLET FORMULATION OF NIACIN - The present invention relates to an extended release tablet formulation comprising niacin and a release retarding agent selected from hydroxypropyl cellulose, polyethylene oxide or mixtures thereof. | 06-10-2010 |
| 20100178341 | BILAYERED TABLET COMPRISING NIACIN AND HMG-CoA REDUCTASE INHIBITOR - The present invention relates to a bilayered tablet comprising: a slow release layer comprising niacin and release retarding agent; and an immediate release layer comprising HMG-CoA reductase inhibitor. | 07-15-2010 |
Rajesh Gandhi, Haryana IN
| Patent application number | Description | Published |
|---|---|---|
| 20080279951 | Stable Oral Benzimidazole Compositions Prepared by Non-Aqueous Layering Process - The present invention relates to processes for the preparation of stable oral compositions of benzimidazole compounds prepared using a non-aqueous layering process. | 11-13-2008 |
| 20090162449 | STABLE ORAL BENZIMIDAZOLE COMPOSITIONS AND PROCESS OF PREPARATION THEREOF - The present invention relates to stable oral compositions of one or more benzimidazole compounds and processes for their preparation. Also provided are methods for treating various gastrointestinal disorders. | 06-25-2009 |
Rujuswami Daxesh Gandhi, Bhavnagar IN
| Patent application number | Description | Published |
|---|---|---|
| 20120124199 | PERFORMANCE OPTIMIZATION THROUGH RUN-TIME QUALITY GOVERNANCE - The present invention provides a method and system for optimizing the performance of a service according to the load on the service. The invention includes altering the quality of various sub-ordinate services that are a part of the service and in turn achieving systemic service performance levels that satisfy prescribed service level agreements. | 05-17-2012 |
Salil Gandhi, Pune IN
| Patent application number | Description | Published |
|---|---|---|
| 20100125402 | SYSTEM AND METHOD FOR CONTROLLING VEHICLE ENGINE RUNNING STATE AT BUSY INTERSECTIONS FOR INCREASED FUEL CONSUMPTION EFFICIENCY - The present disclosure is directed to a method for managing engines in response to a traffic signal. The method may comprise establishing communications with participating vehicles; responding to a stop status indicated by the traffic signal, further comprising: receiving a position data from each participating vehicles; determining a queue of participating vehicles stopped at the traffic signal; determining a remaining duration of the stop status; sending a stop-engine notification to the list of participating vehicles stopped at the traffic signal when the remaining duration is greater than a threshold of time; responding to a proceed status indicated by the traffic signal, further comprising: sending a start-engine notification to a first vehicle in the queue; calculating an optimal time for an engine of a second vehicle in the queue to start; and sending the start-engine notification to the second vehicle at the optimal time. | 05-20-2010 |
Salil P. Gandhi, Pune IN
| Patent application number | Description | Published |
|---|---|---|
| 20100291972 | Automatic Setting Of Reminders In Telephony Using Speech Recognition - Systems and methods for automatically setting reminders. A method for automatically setting reminders includes receiving utterances, determining whether the utterances match a stored phrase, and in response to determining that there is a match, automatically setting a reminder in a mobile communication device. Various filters can be applied to determine whether or not to set a reminder. Examples of suitable filters include location, date/time, callee's phone number, etc. | 11-18-2010 |
| 20110164059 | RESCALING FOR INTEROPERABILITY IN VIRTUAL ENVIRONMENTS - Exemplary embodiments include a method for transferring objects from a first virtual environment residing on a first computer system to a second virtual environment residing on a second computer system, the method including determining whether dimensions of the second virtual environment are compatible with dimensions of the first virtual environment, in response to a determination that the dimensions of the second virtual environment are not compatible with the dimensions of the first virtual environment, performing an interoperability rescaling between the first virtual environment and the second virtual environment and transferring the object from the first virtual environment to the second virtual environment. | 07-07-2011 |
| 20110173271 | ELECTRONIC MAIL MESSAGING SYSTEM - A method, a system and a computer program product of transmitting availability information in an electronic mail system are disclosed. The system includes a first system including a sender, the first system is adapted to activate an availability indicator having a start date, wherein the activation is performed by the sender and extract availability indicator metadata from the availability indicator. The availability indicator metadata includes the start date, an end date, and at least one availability indicator message. If an e-mail has not been sent to a receiver since activation and if a current date is prior to the start date, the first system is further adapted to attach the availability indicator metadata to the e-mail, and send the e-mail to the receiver. The electronic mail system further includes a scheduling system functionally coupled to the first system, and is adapted to define the availability indicator. | 07-14-2011 |
| 20110314106 | USER INITIATED RULE-BASED RESTRICTIONS ON MESSAGING APPLICATIONS - A method, system and computer program product are disclosed for user initiated rule based restrictions on sending messages from a sender to a receiver in a communications network. The receiver establishes a set of rules for the sender that allows the sender a limited number of defined messages events with the receiver. The defined message events may be messages or message sessions. When the sender attempts to send a message to the receiver, it is determined whether a message session currently exists between the sender and the receiver. If a current session exists, the rules set by the receiver are used to determine if the message is allowed to be sent to the receiver. If a session does not currently exist, the rules are used to determine whether a new session is allowed. If a new message session is allowed, a new session is established, and the message is sent to the receiver during the new session. | 12-22-2011 |
Salil P. Gandhi, Yerwada IN
| Patent application number | Description | Published |
|---|---|---|
| 20110004474 | Audience Measurement System Utilizing Voice Recognition Technology - A method, a system, and a computer program product for determining a total count of audience members within a sensory receiving environment during the presentation of a program. A voice recognition unit is enabled when a signal for a program/subject/event, such as a broadcast program, is received. The voice recognition unit receives one or more sounds in the sensory receiving environment and analyzes the characteristics of the sounds. When one or more unique human voices are identified during the program, a count of the number of unique human voices is determined. The count of unique human voices is transmitted to a server, whereby the count of unique human voices is equal to a count of audience members. The total count of audience members is calculated for all sensory receiving environment associated with the program. An audience analysis graphical user interface is generated to display the total count of audience members. | 01-06-2011 |
| 20110004477 | Facility for Processing Verbal Feedback and Updating Digital Video Recorder(DVR) Recording Patterns - A method, a system and a computer program product for using speech/voice recognition technology to update digital video recorder (DVR) program recording patterns, based on program viewer/listener feedback. A speech controlled pattern modification (SCPM) utility utilizes a DVR recording sub-system integrated with speech processing functionality to compare control phrases with phrases uttered by a viewer. If a control phrase matches a phrase uttered by the viewer, the SCPM utility modifies the DVR recording patterns, according to a set of pre-programmed governing rules. For example, the SCPM utility may avoid modifying the recording patterns for programs within a list of “favorite” programs but may modify the recording patterns for programs excluded from the list. The SCPM utility determines priority of the uttered phrases by identifying users and retrieving a preset priority level of the identified users. The priority level is then used to control changes to the recording patterns. | 01-06-2011 |
| 20110004624 | Method for Customer Feedback Measurement in Public Places Utilizing Speech Recognition Technology - A method, a system and a computer program product for enabling a customer response speech recognition unit to dynamically receive customer feedback. The customer response speech recognition unit is positioned at a customer location. The speech recognition unit is automatically initialized when one or more spoken words are detected. The response statements of customers are dynamically received by the customer response speech recognition unit at the customer location, in real time. The customer response speech recognition unit determines when the one or more spoken words of the customer response statement are associated with a score in a database. An analysis of the words is performed to generate a score that reflects the evaluation of the subject by the customer. The score is dynamically updated as new evaluations are received, and the score is displayed within graphical user interface (GUI) to be viewed by one or more potential customers. | 01-06-2011 |
Yash Gandhi, Maharashtra IN
| Patent application number | Description | Published |
|---|---|---|
| 20100095120 | TRUSTED AND CONFIDENTIAL REMOTE TPM INITIALIZATION - Techniques are provided to allow remote initialization of a Trusted Platform Module. The results may be trusted and confidential even if the target device has malicious operating system or other software running. | 04-15-2010 |
Yash Ashok Kumar Gandhi, Ramdaspeth Nagpur IN
| Patent application number | Description | Published |
|---|---|---|
| 20100082987 | TRANSPARENT TRUST VALIDATION OF AN UNKNOWN PLATFORM - A transparent trust validation of an unknown platform can be performed by communicationally coupling it to a trusted device, such as a portable peripheral device carried by a user, or one or more remote computing devices. Information from the unknown platform can be obtained by boot code copied to it from the trusted device and such information can be validated by the trusted device. The trusted device can then provide an encrypted version of decryption key to the boot code which can request the Trusted Platform Module (TPM) of the unknown platform to decrypt and return the decryption key. If the information originally obtained from the unknown platform and validated by the trusted device was authentic, the TPM will be able to provide the decryption key to the boot code, enabling it to decrypt an encrypted volume comprising applications, operating systems or other components. | 04-01-2010 |